REVENUES

3 Months Ended

Mar. 31, 2024

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended March 31,
(U.S. dollars in thousands)	2024		2023
Pfizer	$	1,127	$	2,266
Brazil	$	2,550	$	2,800
Total revenues from selling goods	$	3,677	$	5,066
Revenues from license and R&D services	$	71	$	4,522